Alector (ALEC) Capital Expenditures (2018 - 2026)
Alector (ALEC) posted quarterly Capital Expenditures of $30000.0 for Q1 2026, up 50.0% year-over-year from $20000.0 in Q1 2025, and down 26.83% quarter-over-quarter from $41000.0 in Q4 2025.
Alector (ALEC) Capital Expenditures (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Capital Expenditures for 9 consecutive years, with $30000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures rose 50.0% year-over-year to $30000.0; the TTM figure through Mar 2026 stood at $51000.0 (down 93.13% YoY), while the FY2025 annual figure was $41000.0, down 96.73% from the prior year.
- Capital Expenditures eased to $30000.0 in Q1 2026 per ALEC's latest filing, from $41000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.9 million in Q3 2022 and bottomed at -$2.9 million in Q4 2022.
- Historically, Capital Expenditures has averaged $262500.0 across 5 years, with a median of $321000.0 in 2023.
- On a YoY basis, Capital Expenditures climbed as much as 1809.82% in 2022 and fell as far as 709.38% in 2022.
- Alector's Capital Expenditures stood at -$2.9 million in 2022, then surged by 108.15% to $233000.0 in 2023, then surged by 427.04% to $1.2 million in 2024, then tumbled by 96.66% to $41000.0 in 2025, then declined by 26.83% to $30000.0 in 2026.
- Business Quant data shows ALEC's Capital Expenditures at $30000.0 in Q1 2026, $41000.0 in Q4 2025, and -$20000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | 31,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31,000.00 |
| Jun 30, 2026 | 31,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | 41,000.00 |
| Dec 31, 2025 | 41,000.00 |
| Jun 30, 2025 | -20,000.00 |
| Jun 30, 2025 | -20,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 1.23 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Sep 30, 2024 | -843,000.00 |
| Sep 30, 2024 | -843,000.00 |
| Jun 30, 2024 | 337,000.00 |
| Jun 30, 2024 | 337,000.00 |
| Mar 31, 2024 | 533,000.00 |
| Mar 31, 2024 | 533,000.00 |
| Dec 31, 2023 | 233,000.00 |
| Dec 31, 2023 | 233,000.00 |